M
Michael E. Sughrue
Researcher at University of Oklahoma Health Sciences Center
Publications - 320
Citations - 8960
Michael E. Sughrue is an academic researcher from University of Oklahoma Health Sciences Center. The author has contributed to research in topics: Medicine & Meningioma. The author has an hindex of 48, co-authored 284 publications receiving 7058 citations. Previous affiliations of Michael E. Sughrue include University of Oklahoma & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Erratum: Association of morbidity with extent of resection and cavernous sinus invasion in sphenoid wing meningiomas (Skull Base DOI: 10.1055/s-0032-1304562)
Michael E. Ivan,Jason S. Cheng,Gurvinder Kaur,Michael E. Sughrue,Aaron J. Clark,Ari J. Kane,Derick Aranda,Michael W. McDermott,Igor J. Barani,Andrew T. Parsa +9 more
Journal ArticleDOI
Aggressive Progression of a WHO Grade I Meningioma of the Posterior Clinoid Process: An Illustration of the Risks Associated With Observation of Skull Base Meningiomas.
TL;DR: In this article, the authors report the case of an incidentally discovered small, right-sided posterior clinoid meningioma in a 53-year-old female, which was managed conservatively but an annual surveillance magnetic resonance imaging demonstrated that the meningus had an unexpected significant growth impinging on the brainstem, requiring surgical resection and radiosurgery for residual tumor.
Journal ArticleDOI
Neurosurgery Clinics of North America. Minimally invasive intracranial surgery. Preface.
Michael E. Sughrue,Charles Teo +1 more
TL;DR: The present issue of Neurosurgery Clinics of North America aims to summarize the rapidly growing range of neurosurgical techniques being utilized worldwide to reduce the impact of intracranial procedures on patients, and suggests that the best surgery for a given lesion is the one that involves the least exposure or manipulation of the brain, neural structures, or critical vessels, yet achieves the goals of surgery.
Journal ArticleDOI
Pharmacotherapeutic options for atypical meningiomas.
TL;DR: In this short review, the authors have searched the current literature for explorations of adjuvant treatments such as chemotherapy and pharmaceutical agents and found drugs like somatostatin analogs and plant-derived chemotherapeutics have shown some promise.